Radiation-induced activation of ErbB2, ErbB3 and IGF-1R in breast carcinoma cells expressing low EGFR levels

被引：0
|
作者：
Luo, Xuemei [1 ]
Mikkelsen, Ross B. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4386
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression of ErbB2 enhances radiation-induced NF-κB activation
    Guo, GZ
    Wang, TL
    Gao, Q
    Tamae, D
    Wong, P
    Chen, T
    Chen, WC
    Shively, JE
    Wong, JYC
    Li, JJ
    ONCOGENE, 2004, 23 (02) : 535 - 545
  • [22] Mesenchymal stem cells drive paclitaxel resistance in ErbB2/ErbB3/-coexpressing breast cancer cells via paracrine of neuregulin 1
    Chen, Jin
    Ren, Qun
    Cai, Yuanming
    Lin, Tingting
    Zuo, Weimin
    Wang, Jin
    Lin, Rong
    Zhu, Ling
    Wang, Ping
    Dong, Huiyue
    Zhao, Hu
    Huang, Lianghu
    Fu, Yunfeng
    Yang, Shunliang
    Tan, Jianming
    Lan, Xiaopeng
    Wang, Shuiliang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 501 (01) : 212 - 219
  • [23] Estrogenic Promotion of ErbB2 Tyrosine Kinase Activity in Mammary Tumor Cells Requires Activation of ErbB3 Signaling
    Liu, Bolin
    Ordonez-Ercan, Dalia
    Fan, Zeying
    Huang, Xiaoping
    Edgerton, Susan M.
    Yang, XiaoHe
    Thor, Ann D.
    MOLECULAR CANCER RESEARCH, 2009, 7 (11) : 1882 - 1892
  • [24] Signaling via ErbB2 and ErbB3 associates with resistance and Epidermal Growth Factor Receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells
    Erjala, Kaisa
    Sundvall, Maria
    Junttila, Teemu T.
    Zhang, Na
    Savisalo, Mika
    Mali, Pekka
    Kulmaia, Jarmo
    Pulkkinen, Jaakko
    Grenman, Reidar
    Elenius, Klaus
    CLINICAL CANCER RESEARCH, 2006, 12 (13) : 4103 - 4111
  • [25] CYANIDIN-3-GLUCOSIDE INHIBITS ETHANOL-INDUCED INVASION OF BREAST CANCER CELLS EXPRESSING HIGH LEVELS OF ERBB2
    Xu, M.
    Bower, K. A.
    Chen, G.
    Ke, Z. J.
    Luo, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 14A - 14A
  • [26] HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via downregulation of both erbB3 and erbB2 expression
    Huang, Xiaoping
    Gao, Lizhi
    Wang, Shuiliang
    Lee, Choon-Kee
    Ordentlich, Peter
    Liu, Bolin
    CANCER RESEARCH, 2009, 69
  • [27] Expression levels of EGFR, ERBB2, and ERBB3 compared to cellular radiation sensitvity and the response to EGFR inhibitors C225 and BIBX1382BS in human tumour cell lines in vitro
    Eicheler, W.
    Doerfler, A.
    Krause, M.
    Baumann, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S30 - S31
  • [28] Lycopene inhibits cell growth and decreases the levels of ErbB2 and ErbB3 in human colon cancer HT-29 cells.
    Jung, JI
    Khachik, F
    Kim, EJ
    Park, JHY
    FASEB JOURNAL, 2002, 16 (05): : A1006 - A1006
  • [29] Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-Tooth disease type 1A
    Massa, R
    Palumbo, C
    Cavallaro, T
    Panico, MB
    Bei, R
    Terracciano, C
    Rizzuto, N
    Bernardi, G
    Modesti, A
    MUSCLE & NERVE, 2006, 33 (03) : 342 - 349
  • [30] Valproic acid reverses trastuzumab resistance in erbB2-positive breast cancer cells via downregulation of ErbB2/ErbB3 signaling through induction of ErbB family members-targeting miRNAs
    Lin, Tingting
    Ren, Qun
    Zuo, Weimin
    Lin, Rong
    Zhao, Hu
    Wang, Ping
    Tan, Jianming
    Lyu, Hui
    Liu, Bolin
    Wang, Shuiliang
    CANCER RESEARCH, 2018, 78 (13)
12345